Brief: Amplitude Surgical To Review Novastep's Foot, Ankle Activities

Amplitude Surgical SA

28/06/2022 17:12

June 28 (Reuters) - AMPLITUDE SURGICAL SA  AMPLI.PA :
    * LAUNCH OF A STRATEGIC REVIEW OF NOVASTEP'S FOOT AND ANKLE
ACTIVITIES
    * REVIEW THAT WOULD BE CARRIED OUT BY GROUP COULD EVENTUALLY
LEAD
TO DIVESTMENT OF THIS ACTIVITY
    * IN COMING WEEKS, GROUP WILL APPOINT FINANCIAL ADVISORS TO
ASSIST
WITH THIS REVIEW
    * TARGETS A RETURN TO PRE-COVID GROWTH TRAJECTORY AFTER AN
INITIAL
UPTURN IN GROWTH IN 2021-22, RESULTING IN ANNUAL SALES OF
APPROXIMATELY EUR 129 MILLION IN 2022-23 (FY TO JUNE 30, 2023)
    * TARGETS AN EBITDA MARGIN OF AROUND 21% IN 2022-23 (FY TO
JUNE
30, 2023)
    * FOR ITS 2021-22 FINANCIAL YEAR TO JUNE 30, 2022, GROUP IS
ANTICIPATING SALES OF APPROXIMATELY EUR 104 TO 105 MILLION AND
AN EBITDA MARGIN OF AROUND 20%
    * NOVASTEP SHOULD ACCOUNT FOR SOME 17% OF GROUP'S ANNUAL
SALES

Source text for Eikon:  ID:nBw3M8cHga 
Further company coverage:  AMPLI.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))